Cargando…

Antibody Therapeutics in Oncology

One of the newer classes of targeted cancer therapeutics is monoclonal antibodies. Monoclonal antibody therapeutics are a successful and rapidly expanding drug class due to their high specificity, activity, favourable pharmacokinetics, and standardized manufacturing processes. Antibodies are capable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wold, Erik D, Smider, Vaughn V, Felding, Brunhilde H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829403/ https://www.ncbi.nlm.nih.gov/pubmed/27081677

Ejemplares similares

Formation of ultralong DH regions through genomic rearrangement
por: Smider, Brevin A., et al.
Publicado: (2020)

Diversity in the Cow Ultralong CDR H3 Antibody Repertoire
por: Haakenson, Jeremy K., et al.
Publicado: (2018)

A Broad Role for Cysteines in Bovine Antibody Diversity
por: Haakenson, Jeremy K., et al.
Publicado: (2019)

A Genetically Encoded aza-Michael Acceptor for Covalent Cross-Linking of Protein–Receptor Complexes
por: Furman, Jennifer L., et al.
Publicado: (2014)

CKS protein overexpression renders tumors susceptible to a chemotherapeutic strategy that protects normal tissues
por: Tat, John, et al.
Publicado: (2017)

Structural basis of broad HIV neutralization by a vaccine-induced cow antibody
por: Stanfield, Robyn L., et al.
Publicado: (2020)

Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
por: Davda, Jasmine, et al.
Publicado: (2019)

Milking the Cow: Cattle-Derived Chimeric Ultralong CDR-H3 Antibodies and Their Engineered CDR-H3-Only Knobbody Counterparts Targeting Epidermal Growth Factor Receptor Elicit Potent NK Cell-Mediated Cytotoxicity
por: Pekar, Lukas, et al.
Publicado: (2021)

Evolution of surrogate light chain in tetrapods and the relationship between lengths of CDR H3 and VpreB tails
por: Ott, Jeannine A., et al.
Publicado: (2022)

Guide to Therapeutic Oncology
por: Scarffe, J. H.
Publicado: (1980)

Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID
por: Cusi, Maria Grazia, et al.
Publicado: (2023)

Fixed Dosing of Monoclonal Antibodies in Oncology
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2017)

Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows
por: Sok, Devin, et al.
Publicado: (2017)

Identification of a novel immune checkpoint regulator and potential therapeutic antibody target in oncology
por: Sallee, Nathan, et al.
Publicado: (2015)

Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncology
por: Chatelut, Etienne, et al.
Publicado: (2021)

Manual of oncologic therapeutics /
Publicado: (1995)

Therapeutic Advances in Oncology
por: Liu, Jinsha, et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology
por: van der Kleij, Maud B. A., et al.
Publicado: (2023)

A Single Immunoglobulin-like Domain of the Human Neural Cell Adhesion Molecule L1 Supports Adhesion by Multiple Vascular and Platelet Integrins
por: Felding-Habermann, Brunhilde, et al.
Publicado: (1997)

Recent Advances in Oligonucleotide Therapeutics in Oncology
por: Xiong, Haoyu, et al.
Publicado: (2021)

Sagacious epitope selection for vaccines, and both antibody-based therapeutics and diagnostics: tips from virology and oncology
por: Gan, Samuel Ken-En, et al.
Publicado: (2022)

A Single-Step Chemoenzymatic Reaction for the Construction of Antibody–Cell Conjugates
por: Li, Jie, et al.
Publicado: (2018)

Therapeutics for paediatric oncological emergencies
por: Leung, Karen Ka Yan, et al.
Publicado: (2021)

Therapeutic Options in Neuro-Oncology
por: Afonso, Mariana, et al.
Publicado: (2022)

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno‐Oncology and Beyond: Challenges, Perspectives, and Prospects
por: Dai, Haiqing Isaac, et al.
Publicado: (2020)

The Role of Antibody-Based Therapies in Neuro-Oncology
por: Ramapriyan, Rishab, et al.
Publicado: (2023)

Structures of the T cell potassium channel Kv1.3 with immunoglobulin modulators
por: Selvakumar, Purushotham, et al.
Publicado: (2022)

Editorial: Insights in neuro-oncology and neurosurgical oncology: 2021
por: Sulman, Erik P., et al.
Publicado: (2023)

“Therapeutic Antibodies”
por: McCluskey, D R
Publicado: (1996)

Antisense therapeutics in oncology: current status
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2014)

Editorial: Cardio-oncology: mechanisms and therapeutics
por: Ma, Yan, et al.
Publicado: (2023)

Association of anticardiolipin antibodies with epilepsy in children
por: Shiva, Shadi, et al.
Publicado: (2023)

Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology
por: Verheijen, Remy B., et al.
Publicado: (2017)

Editorial: 365 days of progress in neuro-oncology and neurosurgical oncology
por: Sulman, Erik P., et al.
Publicado: (2023)

Antibody Phage Display Libraries: Contributions to Oncology
por: Dantas-Barbosa, Carmela, et al.
Publicado: (2012)

An overview of antibody–drug conjugates in oncological practice
por: Theocharopoulos, Charalampos, et al.
Publicado: (2020)

Antibody–Biopolymer Conjugates in Oncology: A Review
por: Chavda, Vivek P., et al.
Publicado: (2023)

Advances in the applications of monoclonal antibodies in clinical oncology. Abstracts.
Publicado: (1984)

Monitoring Monoclonal Antibody Delivery in Oncology: The Example of Bevacizumab
por: Nugue, Guillaume, et al.
Publicado: (2013)

Nineteen-Step Total Synthesis of (+)-Phorbol
por: Kawamura, Shuhei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tdfrcmttdpi4b4vh7n2u2ddnni